This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| ICD-10 | M45.6 |
| Synonyms / related terms | Ankylosing spondylitis with lumbar involvement, lumbar AS, ankylosing spondylitis with cauda equina syndrome |
| Special Copayment Reduction | V140 — Severe intractable disease (copayment 10%, 5 years) |
| Main age of onset | Onset at ages 15-35; lumbar involvement appears from the early stage of AS together with sacroiliac joint involvement |
Contents
| s1 | History |
| s2 | Causes |
| s3 | Genetics |
| s4 | General epidemiology |
| s5 | Pathophysiology |
| s6 | Symptoms |
| s7 | Signs |
| s8 | Screening |
| s9 | Diagnosis |
| s10 | Treatment |
| s11 | Prognosis |
| s12 | Prevention |
| s13 | References |
Lumbar spine (L1-L5) involvement in ankylosing spondylitis (AS) is the most central site of involvement in the clinical course of AS and, together with sacroiliac joint involvement, forms the radiographic basis of AS diagnosis. Historically, after the clinical descriptions by Bechterew, Marie, and Strümpell in 1897, low back pain became established as the most typical symptom of AS. Because decreased lumbar range of motion and low back pain were included as clinical criteria in the 1984 modified New York criteria, lumbar involvement became a core element of AS diagnosis. The mSASSS (modified Stoke AS Spinal Score), which tracks radiographic progression of lumbar AS (syndesmophyte formation, lumbar bony fusion), was developed to include the lumbar and cervical spine. Cauda equina syndrome (CES) is the most serious neurological complication of lumbar AS, occurring after long-standing disease and causing bladder, bowel, and sexual dysfunction and motor and sensory paralysis of the lower limbs. Since the biologic era, research on suppressing lumbar radiographic progression has been active, and evidence is accumulating that early treatment improves lumbar functional outcomes.
The causes of lumbar AS share the risk factors of systemic AS, and the lumbar spine is the spinal region subject to the greatest mechanical load, where enthesis stress is concentrated. HLA-B27 positivity, long disease duration, smoking, and male sex are the main risk factors for lumbar radiographic progression. A pathway has been proposed in which gut microbiome abnormalities (overgrowth of Klebsiella pneumoniae) trigger an autoimmune response at the lumbar-pelvic entheses through molecular mimicry. Repetitive flexion and extension loading of the lumbar spine sustains enthesitis of the anterior vertebral corners and facet joints and accelerates syndesmophyte formation. Inadequate NSAID or TNF inhibitor treatment increases the rate of lumbar radiographic progression. CES occurs when dural sac ectasia, epidural fat hypertrophy, foraminal stenosis, and reactive dural adhesions jointly compress the lumbar cauda equina.
The genetic basis of lumbar AS centers on the genetic risk factors of systemic AS (HLA-B27, ERAP1, IL23R, IL12B). Decreased levels of DKK-1 (Dickkopf-1) and sclerostin promote syndesmophyte formation through overactivation of Wnt signaling, and polymorphisms in genes regulating their expression are associated with the rate of lumbar radiographic progression. Polymorphisms of RUNX2 (runt-related transcription factor 2) and SOX9 may affect osteoblast differentiation and regulate the pattern of lumbar bone formation. Genetic factors specific to the development of cauda equina syndrome have not yet been identified, but genetic variants related to connective tissue properties that cause dural sac abnormalities may contribute. Osteoporosis-related genetic factors increase the risk of lumbar compression fracture.
Lumbar AS is the most common site of involvement in AS, and clinical low back pain is present in nearly all patients from the time of diagnosis. Lumbar radiographic changes (syndesmophytes) occur in about 50-70% with an AS disease duration of 10 years or more. Cauda equina syndrome is a rare complication occurring in about 0.3-1% of AS patients, but when it occurs it is a serious complication causing irreversible functional impairment. The prevalence of osteoporosis in lumbar AS patients is about 25-35%, higher than in the general population. Lumbar compression fractures are relatively common in AS patients with osteoporosis. In Korean AS cohorts, lumbar involvement is an essential element of AS diagnosis and is evaluated in all patients. Male sex, HLA-B27 positivity, smoking, and high CRP are independent predictors of lumbar radiographic progression.
The core pathology of lumbar AS is enthesitis beginning with the sagittal Romanus lesion (shiny corner) at the anterior vertebral corner. As TNF-α- and IL-17A-mediated inflammation of the anterior annulus fibrosus-vertebral junction recurs, reactive BMP/Wnt activation forms syndesmophytes (squaring of the vertebra → syndesmophyte → bony bridge). Synovial inflammation of the facet joints and ossification of the ligamentum flavum progressively narrow the lumbar canal. The pathophysiology of CES is not yet fully elucidated, but mechanisms in which epidural fat proliferation, cystic dural expansion, and arachnoiditis compress the cauda equina have been proposed. Lumbar osteoporosis increases the fragility of the anterior vertebral trabeculae and causes compression fractures. There is clinical evidence that long-term NSAID use suppresses reactive syndesmophyte formation at this site.
The core symptom of lumbar AS is chronic inflammatory low back pain, characterized by onset before age 40, duration of 3 months or more, worsening at rest, improvement with exercise, nocturnal pain (waking in the second half of the night), and morning stiffness lasting 45 minutes or more. A marked response to NSAID treatment is also a feature of inflammatory back pain. Decreased lumbar range of motion progresses sequentially until forward flexion, lateral flexion, and extension are all restricted. Lumbar radiculopathy is common at the L4-L5 and L5-S1 segments and presents as sciatica, radiating pain in the lower limb, and paresthesia of the dorsum of the foot or the heel. When CES occurs, saddle anesthesia, symmetric lower limb weakness, and bladder (urinary retention or incontinence), bowel (constipation or fecal incontinence), and sexual dysfunction appear progressively and emergency treatment is needed.
The main sign of lumbar AS is restricted lumbar flexion, quantified by an abnormal Schober test (normal increase of 5 cm or more; decreased in AS). The modified Schober test (normal 10 cm or more; decreased in AS) is also used. Decreased lateral lumbar flexion (one item of the BASMI) is observed. Flattening of lumbar lordosis is seen on lateral radiographs. Reduced ability to maintain a horizontal forward gaze and abnormal upright posture appear in long-standing disease. The sciatic nerve tension test (straight leg raise test) may be positive when lumbar radiculopathy coexists, but is generally negative in AS alone. When CES is suspected, anal sphincter tone, the anal reflex, and saddle sensation must be checked.
For screening of lumbar AS, anteroposterior and lateral lumbar and pelvic radiographs are performed regularly, and lumbar radiographic progression is tracked with the mSASSS score. MRI (lumbar, T2/STIR) is essential for evaluating active lumbar inflammation, bone marrow edema, dural sac abnormalities, and early findings of CES. Bone density (DEXA, L1-L4) is measured regularly, taking into account that lumbar bony fusion can overestimate DEXA values. The ASDAS and BASDAI are used to monitor disease activity. When bladder dysfunction is suspected, urodynamic studies and dural MRI (evaluation of the cauda equina) are performed. When neurological abnormalities appear, emergency MRI and neurosurgical consultation are needed.
A diagnosis of lumbar AS is made by meeting the modified New York criteria (inflammatory back pain + decreased lumbar range of motion + radiographic criteria). Confirmation of active sacroiliac joint inflammation by MRI (ASAS 2009 criteria) also makes it possible to diagnose non-radiographic axial spondyloarthritis (nr-axSpA), a stage before radiographic changes. The diagnosis of CES is established when clinical symptoms (saddle anesthesia, bladder and bowel dysfunction, lower limb weakness) and dural sac abnormalities and cauda equina compression are confirmed on MRI. Differentiation from degenerative low back pain, lumbar spinal stenosis, infectious spondylitis, and DISH is needed. When neurological symptoms appear, immediate neurosurgical consultation is needed.
Drug treatment of lumbar AS follows the principle of NSAIDs (indomethacin, naproxen, celecoxib) first line, then TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab, golimumab) or IL-17A inhibitors (secukinumab, ixekizumab) second line. Continuous NSAID administration has clinical evidence of suppressing lumbar syndesmophyte formation. Lumbar stabilization exercises (core muscle strengthening), lumbar extension exercises, and posture correction education are essential for maintaining lumbar function. When CES occurs, emergency surgical decompression (laminectomy, foraminotomy, dural sac decompression) is needed, and early surgery within 48 hours is recommended to maximize the chance of neurological recovery. Existing lumbar disc herniation surgeries (TLIF, PLIF) in lumbar AS are technically more complex than in non-AS patients because of the different spinal anatomy and fragile bone quality of AS patients.
The prognosis of lumbar AS is determined by the rate of lumbar radiographic progression, whether CES occurs, and whether osteoporosis coexists. Radiographic progression is fastest within the first 10 years of onset, and early TNF/IL-17 inhibitor administration and continuous NSAID use slow the rate of radiographic progression. After CES occurs, recovery of neurological function is often incomplete, and bladder and bowel dysfunction are particularly difficult to recover. Osteoporotic lumbar compression fractures cause worsening kyphotic deformity and neurological complications. When complete lumbar bony fusion is achieved, mobility is lost, but inflammatory pain sometimes partly decreases. Early diagnosis and thorough treatment according to the T2T strategy are the most important factors determining long-term lumbar functional outcomes.
Prevention of lumbar AS starts with early diagnosis and thorough treatment. Smoking cessation is the most important modifiable factor for slowing the rate of lumbar radiographic progression. Lumbar stabilization exercises, flexion-extension balance exercises, and swimming are routinely recommended. Regular follow-up with lumbar radiographs and MRI allows early detection of radiographic progression and early findings of CES. Patients need education to undergo MRI evaluation immediately if subtle changes in bladder or bowel function (sense of residual urine, worsening constipation, sexual dysfunction) appear. Posture correction at work that minimizes long-distance driving and excessive lumbar flexion load is recommended. Osteoporosis management (bisphosphonates, vitamin D/calcium) and fall prevention reduce the risk of lumbar fracture.
1. van der Linden S, et al. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-8.
2. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8-18.
3. Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.
4. Poddubnyy D, et al. Rates and predictors of radiographic spinal progression in AS. Ann Rheum Dis. 2011;70(8):1369-74.
5. Baraliakos X, et al. MRI in AS: patterns of spinal changes. Rheumatology. 2017;56(3):421-32.
6. Reveille JD. Genetics of spondyloarthritis — beyond the MHC. Nat Rev Rheumatol. 2012;8(5):296-304.
7. Klingberg E, et al. Osteoporosis in ankylosing spondylitis — prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108.
8. Ramiro S, et al. ASAS-EULAR recommendations for AS management: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.
9. Kim TH, et al. Spondyloarthropathies in Korea: prevalence and clinical characteristics. J Korean Med Sci. 2021;36(12):e96.
10. Wanders AJ, et al. NSAIDs inhibit radiographic progression in AS. Arthritis Rheum. 2005;52(6):1756-65.